Rising Prevalence of Hematological Disorders Fosters Growth in Immunohematology Market
Some of the most notable and prominent factors influencing the demand dynamics in the global immunohematology market include increasing awareness among the global population pertaining to the importance of blood donation as well as rising requirement for effective detection and diagnosis of blood related diseases. Various public as well as private entities, along with various non-governmental organizations or NGOs are organizing awareness campaigns to underscore the importance of blood donation. Several organizations are also promoting awareness regarding to the usage of safe blood and blood products. These trends are anticipated to work favorably for the enhancement of the global immunohematology market in coming years.
Rising prevalence of various hematological disorders i.e. diseases associated with blood as well as blood forming organs, is also expected to fuel the demand in the global immunohematology market in coming years. Some of the most notable types of hematological disorders are thalassemia, leukemia, sickle cell anemia, lymphoma, and hemophilia, among others. For example, as per the study by the World Health Organization in 2020, around 4,74,519 new cases of leukemia were reported in 2020. Furthermore, more than 3,11,594 deaths were caused by leukemia in 2020. This rise in the prevalence of leukemia is anticipated to drive the demand for effective treatment and testing solutions in the global immunohematology market within the next few years.
Moreover, rising healthcare infrastructure upgradation, increase in expenditure on research and development for advancing the diagnosis as well as treatment of various hematological diseases, and favorable government policies and initiatives are also expected to foster the development in the global immunohematology market in the next few years. Advancements in the global immunohematology market have paved way for automated hematological devices, high volume sample output, enhanced patient data management, software upgradation, and increase in the storage capacities. However, these technological advancements have also surged the costs of various devices and software tools in the global immunohematology market. The high cost associated with hematology equipment such as software and devices may hamper the growth in the global immunohematology market in coming years.
Global Immunohematology Market: Snapshot
Rapid increase in the global disease burden and rise in the demand for blood- and plasma-derived products such as platelets, immunoglobulin, and plasma factors are augmenting the demand for immunohematology testing instruments and reagents. The number of patients with different hematological and other chronic diseases is also increasing rapidly across the world. This is likely to raise the number of surgical procedures in the near future, consequently propelling the demand for blood transfusions. Demand for advanced immunohematology tests in also anticipated to increase during the forecast period in order to maintain the quality standards and safety profiles during blood transfusions.
Awareness among the general public regarding the importance of blood compatibility and transfusion-related diseases is increasing due to the development of health care infrastructure, government campaigns, and increasing per capita income in developed as well as developing countries. Awareness among patients about proper compatibility tests for transfusion is also increasing. Increasing health care expenditure and rising worldwide concerns about medical safety are also driving the global immunohematology market. Moreover, government reimbursement programs in developed as well as developing countries are likely to provide growth opportunities to the immunohematology market in the near future. Demand–supply gap of safe and adequate human blood and plasma is a major bottleneck in the blood transfusion & blood typing industry. According to the World Health Organization, there is a significant difference between the blood demand–supply gap in developing countries and that in developed countries. Developed countries account for more than 50% of the global blood collections. These countries represent only 19% of the global population. Supply disorders in both source materials and finished products, if not managed properly, can hamper the global immunohematology market during the forecast period.
Advancements in the immunohematology technology have led to rapid development in the diagnostic approach toward in vitro study of the antigen–antibody interaction, facilitating improvement in the compatibility reaction between the donor’s blood and the recipient’s blood. Technological improvements in devices and reagents available for immunohematology testing have enabled clinicians to provide proper emergency assistance to patients. These technological advancements include development of automated systems which make the identification process easier and provide more accurate results as compared to manual systems.
Based on product, the global immunohematology market has been segmented into analyzers and reagents. The analyzers segment has been sub-segmented into automatic analyzers and semi-automatic/non-automatic analyzers. Based on application, the global immunohematology market has been divided into blood typing and antibody screening. Based on end-user, the market has been classified into hospitals, academic & research institutes, diagnostic & reference laboratories, and blood banks. The hospitals segment is expected to remain dominant during the forecast period, due to increasing usage of automated analyzers with high throughput in hospitals.
Geographically, the global immunohematology market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2016 and is projected to continue its dominance between 2017 and 2025. Growth of the market in North America is primarily attributable to the increased funding by governments and the private sector and large volumes of blood transfusions. In addition, increased focus on research by pharmaceutical companies and well-established health care infrastructure are major factors driving the market in the region. The market in Europe is projected to expand at a significant CAGR from 2017 to 2025. Europe held the second-largest market share in 2016. High adoption and usage of superior-quality diagnostics and treatments is one of the major factors driving the market in the region. This can be attributed to increasing number of diagnostic laboratories and blood banks, rising government funding for research activities, and growing application of immunohematology in transfusion safety in the region. Asia Pacific is one of the rapidly developing regions in the world. High per capita income has increased the consumption of blood products in the region.
Key companies profiled in the report are Bio-Rad Laboratories, Inc., Grifols, S.A., Ortho Clinical Diagnostics, IMMUCOR, INC., Abbott Laboratories, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA, and Siemens Healthineers. These players are adopting organic and inorganic growth strategies to expand their product offerings, enhance their geographical reach, widen their customer base, and gain market share. In 2016, Grifols, S.A. won a contract for supplying blood-typing solutions to the Red Cross of South Korea. The Malaysian National Blood Bank renewed its contract for Grifols’s NAT technology that analyzes about 450,000 blood donations every year.
The global immunohematology market has been segmented as follows:
|
Product |
|
|
Application |
|
|
End-user |
|
|
Geography |
|
Immunohematology market to reach value of US$ 1,991.8 Mn by 2025
Immunohematology market is projected to expand at a CAGR of 3.5% from 2017 to 2025
Immunohematology market is driven by rising awareness among people in developed as well as developing countries and increasing health care expenditure and rising worldwide concerns about medical safety
North America is projected to be the largest share in the global immunohematology market during the forecast period
Key players in the immunohematology market include Bio-Rad Laboratories, Inc., Grifols S.A., Ortho Clinical Diagnostics, IMMUCOR, INC., Abbott Laboratories, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc.
Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology
Section 3 Executive Summary
3.1 Global Immunohematology Market Snapshot
3.2 Market Share Analysis, by Region, 2016
3.3 Market Opportunity Map
Section 4 Market Overview
4.1 Immunohematology Market Taxonomy
4.2 Key Market Advancements
4.3 Global Immunohematology Market Size (US$ Mn) Forecast, 2015–2025
4.4 Global Immunohematology Market Outlook
Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Immunohematology Market: Porter’s Five Forces Analysis
5.6 Key Success Factors of Top 3 Companies
5.7 Estimated blood donations by WHO region , 2013
5.8 Healthcare Sector Overview
Section 6 Immunohematology Market Analysis, by Product
6.1 Introduction
6.2 Global Immunohematology Market Value Share Analysis, by Product
6.3 Global Immunohematology Market Forecast, by Product
6.3.1 Analyzers
6.3.1.1 Automatic
6.3.1.2 Semi-automatic/Non-automatic
6.3.2 Reagents
6.4 Market Attractiveness Analysis, by Product
6.5 Key Trends
Section 7 Immunohematology Market Analysis, by Application
7.1 Introduction
7.2 Global Immunohematology Market Value Share Analysis, by Application
7.3 Global Immunohematology Market Forecast, by Application
7.3.1 Blood Typing
7.3.2 Antibody Screening
7.4 Market Attractiveness Analysis, by Application
7.5 Key Trends
Section 8 Immunohematology Market Analysis, by End-user
8.1 Introduction
8.2 Global Immunohematology Market Value Share Analysis, by End-user
8.3 Global Immunohematology Market Forecast, by End-user
8.3.1 Hospitals
8.3.1.1 500+ Beds
8.3.1.2 200–499 Beds
8.3.1.3 Less Than 200 Beds
8.3.2 Academic & Research Institutes
8.3.3 Diagnostic & Reference Laboratories
8.3.4 Blood Banks
8.4 Market Attractiveness Analysis, by End-user
Section 9 Immunohematology Market Analysis, by Region
9.1 Global Immunohematology Market Scenario
9.2 Global Immunohematology Market Value Share Analysis, by Region
9.3 Global Immunohematology Market Forecast, by Region
9.4 Market Attractiveness Analysis, by Region
Section 10 North America Immunohematology Market Analysis
10.1 Regional Outlook
10.2 Market Overview
10.3 Market Analysis, by Product
10.3.1 Market Value Share Analysis, by Product
10.3.2 Market Size (US$ Mn) Forecast, by Product
10.3.2.1 Analyzers
10.3.2.1.1 Automatic
10.3.2.1.2 Semi-automatic/Non-automatic
10.3.2.2 Reagents
10.4 Market Analysis, by Application
10.4.1 Market Value Share Analysis, by Application
10.4.2 Market Size (US$ Mn) Forecast, by Application
10.4.2.1 Blood Typing
10.4.2.2 Antibody Screening
10.5 Market Analysis, by End-user
10.5.1 Market Value Share Analysis, by End-user
10.5.2 Market Size (US$ Mn) Forecast, by End-user
10.5.2.1 Hospitals
10.5.2.1.1 500+ Beds
10.5.2.1.2 200–499 Beds
10.5.2.1.3 Less Than 200 Beds
10.5.2.2 Academic & Research Institutes
10.5.2.3 Diagnostic & Reference Laboratories
10.5.2.4 Blood Banks
10.6 Market Analysis, by Country
10.6.1 Market Value Share Analysis, by Country
10.6.2. Market Size (US$ Mn) Forecast, by Country, 2017–2025
10.6.2.1 U.S.
10.6.2.1.1 U.S. Market Size (US$ Mn) Forecast, by Product
10.6.2.1.2 U.S. Market Size (US$ Mn) Forecast, by Application
10.6.2.1.3 U.S. Market Size (US$ Mn) Forecast, by End-user
10.6.2.2 Canada
10.7 Market Attractiveness Analysis
10.7.1 by Country
10.7.2 by Product
10.7.3 by Application
10.7.4 by End-user
Section 11 Europe Immunohematology Market Analysis
11.1 Regional Outlook
11.2 Market Overview
11.3 Market Analysis, by Product
11.3.1 Market Value Share Analysis, by Product
11.3.2 Market Size (US$ Mn) Forecast, by Product
11.3.2.1 Analyzers
11.3.2.1.1 Automatic
11.3.2.1.2 Semi-automatic/Non-automatic
11.3.2.2 Reagents
11.4 Market Analysis, by Application
11.4.1 Market Value Share Analysis, by Application
11.4.2 Market Size (US$ Mn) Forecast, by Application
11.4.2.1 Blood Typing
11.4.2.2 Antibody Screening
11.5 Market Analysis, by End-user
11.5.1 Market Value Share Analysis, by End-user
11.5.2 Market Size (US$ Mn) Forecast, by End-user
11.5.2.1 Hospitals
11.5.2.1.1 500+ Beds
11.5.2.1.2 200–499 Beds
11.5.2.1.3 Less Than 200 Beds
11.5.2.2 Academic & Research Institutes
11.5.2.3 Diagnostic & Reference Laboratories
11.5.2.4 Blood Banks
11.6 Market Analysis, by Country/Sub-region
11.6.1 Market Value Share Analysis, by Country/Sub-region
11.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
11.6.2.1 U.K.
11.6.2.2 Germany
11.6.2.3 France
11.6.2.4 Spain
11.6.2.5 Italy
11.6.2.6 Rest of Europe
11.7 Market Attractiveness Analysis
11.7.1 by Country/Sub-region
11.7.2 by Product
11.7.3 by Application
11.7.4 by End-user
Section 12 Asia Pacific Immunohematology Market Analysis
12.1 Regional Outlook
12.2 Market Overview
12.3 Market Analysis, by Product
12.3.1 Market Value Share Analysis, by Product
12.3.2 Market Size (US$ Mn) Forecast, by Product
12.3.2.1 Analyzers
12.3.2.1.1 Automatic
12.3.2.1.2 Semi-automatic/Non-automatic
12.3.2.2 Reagents
12.4 Market Analysis, by Application
12.4.1 Market Value Share Analysis, by Application
12.4.2 Market Size (US$ Mn) Forecast, by Application
12.4.2.1 Blood Typing
12.4.2.2 Antibody Screening
12.5 Market Analysis, by End-user
12.5.1 Market Value Share Analysis, by End-user
12.5.2 Market Size (US$ Mn) Forecast, by End-user
12.5.2.1 Hospitals
12.5.2.1.1 500+ Beds
12.5.2.1.2 200–499 Beds
12.5.2.1.3 Less Than 200 Beds
12.5.2.2 Academic & Research Institutes
12.5.2.3 Diagnostic & Reference Laboratories
12.5.2.4 Blood Banks
12.6 Market Analysis, by Country/Sub-region
12.6.1 Market Value Share Analysis, by Country/Sub-region
12.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
12.6.2.1 Australia & New Zealand
12.6.2.2 Japan
12.6.2.3 China
12.6.2.4 India
12.6.2.5 Rest of Asia Pacific
12.7 Market Attractiveness Analysis
12.7.1 by Country/Sub-region
12.7.2 by Product
12.7.3 by Application
12.7.4 by End-user
Section 13 Latin America Immunohematology Market Analysis
13.1 Regional Outlook
13.2 Market Overview
13.3 Market Analysis, by Product
13.3.1 Market Value Share Analysis, by Product
13.3.2 Market Size (US$ Mn) Forecast, by Product
13.3.2.1 Analyzers
13.3.2.1.1 Automatic
13.3.2.1.2 Semi-automatic/Non-automatic
13.3.2.2 Reagents
13.4 Market Analysis, by Application
13.4.1 Market Value Share Analysis, by Application
13.4.2 Market Size (US$ Mn) Forecast, by Application
13.4.2.1 Blood Typing
13.4.2.2 Antibody Screening
13.5 Market Analysis, by End-user
13.5.1 Market Value Share Analysis, by End-user
13.5.2 Market Size (US$ Mn) Forecast, by End-user
13.5.2.1 Hospitals
13.5.2.1.1 500+ Beds
13.5.2.1.2 200–499 Beds
13.5.2.1.3 Less Than 200 Beds
13.5.2.2 Academic & Research Institutes
13.5.2.3 Diagnostic & Reference Laboratories
13.5.2.4 Blood Banks
13.6 Market Analysis, by Country/Sub-region
13.6.1 Market Value Share Analysis, by Country/Sub-region
13.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
13.6.2.1 Brazil
13.6.2.2 Mexico
13.6.2.3 Rest of Latin America
13.7 Market Attractiveness Analysis
13.7.1 by Country/Sub-region
13.7.2 by Product
13.7.3 by Application
13.7.4 by End-user
Section 14 Middle East & Africa Immunohematology Market Analysis
14.1 Regional Outlook
14.2 Market Overview
14.3 Market Analysis, by Product
14.3.1 Market Value Share Analysis, by Product
14.3.2 Market Size (US$ Mn) Forecast, by Product
14.3.2.1 Analyzers
14.3.2.1.1 Automatic
14.3.2.1.2 Semi-automatic/Non-automatic
14.3.2.2 Reagents
14.4 Market Analysis, by Application
14.4.1 Market Value Share Analysis, by Application
14.4.2 Market Size (US$ Mn) Forecast, by Application
14.4.2.1 Blood Typing
14.4.2.2 Antibody Screening
14.5 Market Analysis, by End-user
14.5.1 Market Value Share Analysis, by End-user
14.5.2 Market Size (US$ Mn) Forecast, by End-user
14.5.2.1 Hospitals
14.5.2.1.1 500+ Beds
14.5.2.1.2 200–499 Beds
14.5.2.1.3 Less Than 200 Beds
14.5.2.2 Academic & Research Institutes
14.5.2.3 Diagnostic & Reference Laboratories
14.5.2.4 Blood Banks
14.6 Market Analysis, by Country/Sub-region
14.6.1 Market Value Share Analysis, by Country/Sub-region
14.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
14.6.2.1 South Africa
14.6.2.2 GCC
14.6.2.3 South Africa
14.6.2.4 Israel
14.6.2.5 Rest of Middle East & Africa
14.7 Market Attractiveness Analysis
14.7.1 by Country/Sub-region
14.7.2 by Product
14.7.3 by Application
14.7.4 by End-user
Section 15 Company Profiles
15.1 Immunohematology Market Share Analysis, by Company (2016)
15.2 Company Profiles
15.2.1 Bio-Rad Laboratories, Inc.
15.2.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2 Financial Overview
15.2.1.3 Product Portfolio
15.2.1.4 SWOT Analysis
15.2.1.5 Strategic Overview
15.2.2 Grifols, S.A.
15.2.2.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2 Financial Overview
15.2.2.3 Product Portfolio
15.2.2.4 SWOT Analysis
15.2.2.5 Strategic Overview
15.2.3 Ortho Clinical Diagnostics
15.2.3.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2 Financial Overview
15.2.3.3 Product Portfolio
15.2.3.4 SWOT Analysis
15.2.3.5 Strategic Overview
15.2.4 IMMUCOR, INC.
15.2.4.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2 Financial Overview
15.2.4.3 Product Portfolio
15.2.4.4 SWOT Analysis
15.2.4.5 Strategic Overview
15.2.5 Abbott Laboratories
15.2.5.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2 Financial Overview
15.2.5.3 Product Portfolio
15.2.5.4 SWOT Analysis
15.2.5.5 Strategic Overview
15.2.6 Beckman Coulter, Inc.
15.2.6.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2 Financial Overview
15.2.6.3 Product Portfolio
15.2.6.4 SWOT Analysis
15.2.6.5 Strategic Overview
15.2.7 Thermo Fisher Scientific, Inc.
15.2.7.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2 Financial Overview
15.2.7.3 Product Portfolio
15.2.7.4 SWOT Analysis
15.2.7.5 Strategic Overview
15.2.8 Becton, Dickinson and Company
15.2.8.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2 Financial Overview
15.2.8.3 Product Portfolio
15.2.8.4 SWOT Analysis
15.2.8.5 Strategic Overview
15.2.9 Merck KGaA
15.2.9.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2 Financial Overview
15.2.9.3 Product Portfolio
15.2.9.4 SWOT Analysis
15.2.9.5 Strategic Overview
15.2.10 Siemens Healthineers14.2.5 Merck & Co., Inc.
15.2.10.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2 Financial Overview
15.2.10.3 Product Portfolio
15.2.10.4 SWOT Analysis
15.2.10.5 Strategic Overview
List of Tables
Table 01: Global Immunohematology Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 02: Global Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 03: Global Immunohematology Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 04: Global Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 05: Global Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 06: Global Immunohematology Market Size (US$ Mn) Forecast, by Region, 2017–2025
Table 07: North America Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 08: North America Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 09: North America Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
Table 10: North America Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 11: North America Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 12: North America Immunohematology Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 13: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 14: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
Table 15: U.S. Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 16: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 17: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Hospitals (by Analyzers), 2015–2025
Table 18: Europe Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 19: Europe Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 20: Europe Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
Table 21: Europe Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 22: Europe Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 23: Europe Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
Table 24: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 25: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 26: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
Table 27: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 28: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 29: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
Table 30: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 31: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Analyzer, 2015–2025
Table 32: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 33: Latin America Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 34: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 36: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 37: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 38: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 39: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 40: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 41: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 42: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
List of Figures
Figure 01: Global Immunohematology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 02: Market Value Share, by Product (2016)
Figure 03: Market Value Share, by Application (2016)
Figure 04: Market Value Share, by Region (2016)
Figure 05: Global Immunohematology Market Value Share Analysis, by Product, 2016 and 2025
Figure 06: Global Immunohematology Market Value Share Analysis, by Analyzers, 2016 and 2025
Figure 07: Global Immunohematology Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzers, 2015–2025
Figure 08: Global Immunohematology Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents, 2015–2025
Figure 09: Global Immunohematology Market Attractiveness Analysis, by Product
Figure 10: Global Immunohematology Market Value Share, by Application, 2016 and 2025
Figure 11: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Blood Typing, 2015–2025
Figure 12: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Antibody Screening, 2015–2025
Figure 13: Global Immunohematology Market Attractiveness, by Application
Figure 14: Global Immunohematology Market Value Share, by End-user, 2016 and 2025
Figure 15: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2015–2025
Figure 16: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Academic & Research Institutes, 2015–2025
Figure 17: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diagnostic & Reference Laboratories, 2015–2025
Figure 18: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Blood Banks, 2015–2025
Figure 19: Global Immunohematology Market Attractiveness, by End-user
Figure 20: Global Immunohematology Market Value Share, by Region, 2016 and 2025
Figure 21: Global Immunohematology Market Attractiveness, by Region
Figure 22: North America Immunohematology Market Size (US$ Mn) Forecast, 2017–2025
Figure 23: North America Market Attractiveness Analysis, by Country
Figure 24: North America Immunohematology Market Value Share Analysis, by Product, 2016 and 2025
Figure 25: North America Immunohematology Market Value Share Analysis, by Application, 2016 and 2025
Figure 26: North America Immunohematology Market Value Share Analysis, by End-user, 2016 and 2024
Figure 27: North America Immunohematology Market Value Share Analysis, by Country, 2016 and 2025
Figure 28: North America Immunohematology Market Attractiveness Analysis, by Product
Figure 29: North America Immunohematology Market Attractiveness Analysis, by Application
Figure 30: North America Immunohematology Market Attractiveness Analysis, by End-user
Figure 31: Europe Immunohematology Market Size (US$ Mn) Forecast, 2017–2025
Figure 32: Europe Immunohematology Market Attractiveness, by Country/Sub-region
Figure 33: Europe Immunohematology Market Value Share, by Product, 2016 and 2025
Figure 34: Europe Immunohematology Market Value Share, by Application, 2016 and 2025
Figure 35: Europe Immunohematology Market Value Share, by End-user, 2016 and 2025
Figure 36: Europe Immunohematology Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 37: Europe Immunohematology Market Attractiveness, by Product
Figure 38: Europe Immunohematology Market Attractiveness, by Application
Figure 39: Europe Immunohematology Market Attractiveness, by End-user
Figure 40: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 41: Asia Pacific Immunohematology Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 42: Asia Pacific Immunohematology Market Value Share, by Product, 2016 and 2025
Figure 43: Asia Pacific Immunohematology Market Value Share, by Application, 2016 and 2025
Figure 44: Asia Pacific Immunohematology Market Value Share, by End-user, 2016 and 2025
Figure 45: Asia Pacific Immunohematology Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 46: Asia Pacific Immunohematology Market Attractiveness, by Product
Figure 47: Asia Pacific Immunohematology Market Attractiveness, by Application
Figure 48: Asia Pacific Immunohematology Market Attractiveness, by End-user
Figure 49: Latin America Immunohematology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 50: Latin America Immunohematology Market Attractiveness Analysis, by Country/Sub-region, 2017-25
Figure 51: Latin America Immunohematology Market Value Share Analysis, by Product, 2016 and 2025
Figure 52: Latin America Immunohematology Market Value Share Analysis, by Application, 2016 and 2025
Figure 53: Latin America Immunohematology Market Value Share Analysis by End-user, 2016 and 2024
Figure 54: Latin America Immunohematology Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 55: Latin America Immunohematology Market Attractiveness Analysis, by Product
Figure 56: Latin America Immunohematology Market Attractiveness Analysis, by Application
Figure 57: Latin America Immunohematology Market Attractiveness Analysis, by End-user
Figure 58: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, 2015–2025
Figure 59: Middle East & Africa Immunohematology Market Attractiveness, by Country/Sub-region
Figure 60: Middle East & Africa Immunohematology Market Value Share, by Product, 2016 and 2025
Figure 61: Middle East & Africa Immunohematology Market Value Share, by Application, 2016 and 2025
Figure 62: Middle East & Africa Immunohematology Market Value Share, by End-user, 2016 and 2024
Figure 63: Middle East & Africa Immunohematology Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 64: Middle East & Africa Immunohematology Market Attractiveness, by Product
Figure 65: Middle East & Africa Immunohematology Market Attractiveness, by Application
Figure 66: Middle East & Africa Immunohematology Market Attractiveness, by End-user
Figure 67: Market Share of Prominent Key Players: Immunohematology Market, 2016
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Immunohematology Market Insights, 2017-2025
